Abstract
Introduction: Breast conserving surgery (BCS) is increasingly becoming the choice of local treatment in breast cancer, which in up to 10% of cases can be bilateral. There are very limited data on the dose distribution, safety and feasibility of adjuvant bilateral breast radiotherapy, which we are assessing here along with clinically identified pneumonitis, cardiac toxicity and patient outcome.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
